| Financial Year |
March 31 2023 |
| Monetary Funds |
92,034,291.32 |
| Held-for-trading Financial Assets |
1,040,000.00 |
| Notes Receivable |
-- |
| Accounts Receivable |
106,991,029.84 |
| Advances to Suppliers |
83,974,820.82 |
| Other Receivables |
153,204,902.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
3,409,459.81 |
| Dividend Receivable |
-- |
| Inventories |
334,619,311.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,000,000.00 |
| Other Current Assets |
15,503,314.32 |
| Total Current Assets |
791,367,670.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,536,299.08 |
| Investment Properties |
-- |
| Fixed Assetes |
71,871,846.30 |
| Under-construction Projects |
1,371,935.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
913,355,101.62 |
| R&D expenses |
-- |
| Goodwill |
1,473,276,846.37 |
| Long-Term Deferred and Prepaid Expenses |
164,958,557.93 |
| Deferred Income Tax Assets |
7,120.75 |
| Other Non-Current Assets |
72,533,366.23 |
| Sub-Total of Non-Current Assets |
4,104,929,583.11 |
| Total Assets |
4,896,297,253.75 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
126,465,119.93 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,828,266.35 |
| Taxes Payable |
122,888,130.63 |
| Interest Payable |
95,786,065.03 |
| Dividend Payable |
-- |
| Other payables |
2,184,449,060.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
229,110,027.09 |
| Other Current Liabilities |
7,488,367.58 |
| Sub-Total of Current Liabilities |
3,138,361,074.30 |
| Long-term Loans |
130,121,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
9,218,350.00 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,023,865,499.54 |
| Total Liabilities |
4,162,226,573.84 |
| Paid-In Capital(Or Share Stock) |
1,854,853,500.00 |
| Capital Surplus |
4,883,615,079.39 |
| Surplus Reserve |
72,037,045.06 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-5,940,229,493.04 |
| Minority Stockholder's Interest |
-46,195,372.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
780,266,052.44 |
| Owner's Equity（Stockholder's Equity） |
734,070,679.91 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,896,297,253.75 |
